These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 12449450

  • 1. Low-molecular weight heparin: treatment failure in a patient with primary antiphospholipid antibody syndrome.
    Ahmed S, Karim A, Patel D, Siddiqui R, Mattana J.
    Am J Med Sci; 2002 Nov; 324(5):279-80. PubMed ID: 12449450
    [Abstract] [Full Text] [Related]

  • 2. Variability in the international normalised ratio (INR) in patients with antiphospholipid syndrome and positive lupus anticoagulant: should the INR targets be higher?
    Baquero-Salamanca M, Téllez-Arévalo AM, Calderon-Ospina C.
    BMJ Case Rep; 2015 Apr 09; 2015():. PubMed ID: 25858939
    [Abstract] [Full Text] [Related]

  • 3. Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (Hughes syndrome).
    Cuadrado MJ.
    Curr Rheumatol Rep; 2002 Oct 09; 4(5):392-8. PubMed ID: 12217243
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of long-term low molecular weight heparin in patients with antiphospholipid syndrome.
    Vargas-Hitos JA, Ateka-Barrutia O, Sangle S, Khamashta MA.
    Ann Rheum Dis; 2011 Sep 09; 70(9):1652-4. PubMed ID: 21628306
    [Abstract] [Full Text] [Related]

  • 5. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr 09; 22(137):99-101, 103-4. PubMed ID: 23662321
    [Abstract] [Full Text] [Related]

  • 6. Simultaneous intrahepatic and subgaleal hemorrhage in antiphospholipid syndrome following anticoagulation therapy.
    Park IC, Baek YH, Han SY, Lee SW, Chung WT, Lee SW, Kang SH, Cho DS.
    World J Gastroenterol; 2013 Oct 14; 19(38):6494-9. PubMed ID: 24151371
    [Abstract] [Full Text] [Related]

  • 7. Is a therapeutic anticoagulation window needed for delivery when using prophylactic low molecular weight heparin during pregnancy? A retrospective monocentric study.
    Roueli A, Cesario E, Amsellem J, Agman A, Vauthier-Brouzes D, Nizard J.
    Eur J Obstet Gynecol Reprod Biol; 2017 Aug 14; 215():118-123. PubMed ID: 28618257
    [Abstract] [Full Text] [Related]

  • 8. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.
    Ruiz-Irastorza G, Khamashta MA, Hunt BJ, Escudero A, Cuadrado MJ, Hughes GR.
    Arch Intern Med; 2002 May 27; 162(10):1164-9. PubMed ID: 12020188
    [Abstract] [Full Text] [Related]

  • 9. The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome.
    Sayar Z, Burke S, Mittal P, Cohen H.
    Lupus; 2022 Oct 27; 31(12):1485-1490. PubMed ID: 36074077
    [Abstract] [Full Text] [Related]

  • 10. Successful use of fondaparinux in a child with heparin-induced thrombocytopenia.
    Tokgoz H, Caliskan U, Demir M.
    Blood Coagul Fibrinolysis; 2012 Dec 27; 23(8):769-71. PubMed ID: 22964766
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
    DeLoughery TG.
    Crit Care Clin; 2005 Jul 27; 21(3):497-512. PubMed ID: 15992670
    [Abstract] [Full Text] [Related]

  • 13. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH, Spiro TE, Trowbridge AA, Gardiner GA, Whitsett TL, O'Connell MB, Ohar JA, Young TR, Enoxaparin Clinical Trial Group.
    J Bone Joint Surg Am; 2001 Jun 27; 83(6):900-6. PubMed ID: 11407799
    [Abstract] [Full Text] [Related]

  • 14. Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem?
    Balaban M, Stanrić V, Rincić G, Ledinsky M, Grbac L, Stancić N, Tomasić H.
    Acta Clin Croat; 2010 Dec 27; 49(4):469-77. PubMed ID: 21830460
    [Abstract] [Full Text] [Related]

  • 15. Monitoring of anticoagulation in thrombotic antiphospholipid syndrome.
    Cohen H, Efthymiou M, Devreese KMJ.
    J Thromb Haemost; 2021 Apr 27; 19(4):892-908. PubMed ID: 33325604
    [Abstract] [Full Text] [Related]

  • 16. [Antiphospholipid antibodies--risk factors for venous thromboembolism and arterial thrombosis].
    Zawilska K.
    Pol Arch Med Wewn; 2007 Apr 27; 117 Suppl():41-5. PubMed ID: 18778019
    [Abstract] [Full Text] [Related]

  • 17. Deep Venous Thrombosis and Pulmonary Embolism: Current Therapy.
    Wilbur J, Shian B.
    Am Fam Physician; 2017 Mar 01; 95(5):295-302. PubMed ID: 28290648
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of antiphospholipid syndrome].
    Páramo JA, García R, Rodríguez P, Panizo E, Lecumberri R.
    Rev Med Univ Navarra; 2007 Mar 01; 51(4):38-41. PubMed ID: 18303659
    [Abstract] [Full Text] [Related]

  • 19. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F.
    Rev Mal Respir; 2011 Dec 01; 28(10):1265-77. PubMed ID: 22152935
    [Abstract] [Full Text] [Related]

  • 20. Antiphospholipid syndrome in pregnancy.
    Bick RL.
    Hematol Oncol Clin North Am; 2008 Feb 01; 22(1):107-20, vii. PubMed ID: 18207069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.